The role of vorasidenib in the treatment of isocitrate dehydrogenase-mutant glioma. de la Fuente MI, Touat M, van den Bent MJ, Preusser M, et al. Neuro Oncol 2024 Dec 25:noae259. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

de la Fuente MI, Touat M, van den Bent MJ, Preusser M, et al. The role of vorasidenib in the treatment of isocitrate dehydrogenase-mutant glioma. Neuro Oncol 2024 Dec 25:noae259. doi: 10.1093.
PMID: 39723472